Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function

The evidence supporting an initial mycophenolate mofetil (MMF) dose of 2 g daily in tacrolimus-treated renal transplant recipients is limited. In a non-contemporaneous single-centre cohort study we compared the incidence of leukopaenia, rejection and graft dysfunction in patients initiated on MMF 1....

Descripción completa

Detalles Bibliográficos
Autores principales: Dave, Vatsa, Polkinghorne, Kevan R., Leong, Khai Gene, Kanellis, John, Mulley, William R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653942/
https://www.ncbi.nlm.nih.gov/pubmed/33168923
http://dx.doi.org/10.1038/s41598-020-76379-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7653942/
https://www.ncbi.nlm.nih.gov/pubmed/33168923
http://dx.doi.org/10.1038/s41598-020-76379-6

Ejemplares similares